The aims of this study are: (Aim 1) Identify sources of heterogeneous impacts of opioid prevention center (OPC) use on non-fatal and fatal overdose risk among individuals with histories of polysubstance use (PSU); (Aim 2) Estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU, and; (Aim 3) Assess the barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Aims 1 and 2 of this study will use secondary data to identify sources of heterogeneous impacts of OPC use on fatal and nonfatal overdose risk (Aim 1) and estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU (Aim 2). Aim 3 of this study will use qualitative interviews with harm reduction staff to assess barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Study Type
OBSERVATIONAL
Enrollment
500
NYU Langone Health
New York, New York, United States
Incidence of Fatal Overdose
Incidence of fatal overdose will be derived from overdose mortality data from the NYC Office of the Chief Medical Examiner.
Time frame: Up to Month 12
Incidence of Non-Fatal Overdose
Incidence of nonfatal overdose will be assessed using hospitalization and emergency department data from the NYC Regional Health Information Exchange (RHIO) and Statewide Research and Planning Cooperative System (SPARCS).
Time frame: Up to Month 12
Incidence of Psychiatric Services Utilization
Psychiatric services utilization will be assessed from SPARCS, RHIO, and NYS Medicaid.
Time frame: Up to Month 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.